1 Propyl 2',6' pipecoloxylidide,
1-propyl-2',6'-pipecoloxylidide,
AL 381,
AL-381,
AL381,
LEA 103,
LEA-103,
LEA103,
Naropeine,
Naropin,
ropivacaine,
ropivacaine hydrochloride,
ropivacaine monohydrochloride,
ropivacaine monohydrochloride, (S)-isomer,
Ropivacaine hydrochloride,
ROPIVACAINE HCl,
98717-15-8,
Naropin,
Ropivacaine monohydrochloride,
132112-35-7,
UNII-35504LBE2T,
35504LBE2T,
Ropivacaine hydrochloride hydrate,
(S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide hydrochloride,
DSSTox_CID_28353,
DSSTox_RID_82753,
DSSTox_GSID_48379,
(S)-Ropivacaine hydrochloride,
2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-propyl-, monohydrochloride, (S)-,
CHEBI:60803,
CAS-98717-15-8,
NCGC00164597-01,
(S)-ropivacaine hydrochloride (anhydrous),
C17H26N2O.HCl.H2O,
(2S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide hydrochloride,
(2S)-N-(2,6-dimethylphenyl)-1-propyl-piperidine-2-carboxamide hydrochloride,
S-Ropivacaine hydrochloride,
AC1L41QM,
C17H26N2O.ClH,
C17H26N2O.HCl,
ropivacaine monohydrochloride,,
MLS001401363,
SCHEMBL236432,
CHEMBL1889140,
DTXSID2048379,
HY-B0563B,
NDNSIBYYUOEUSV-RSAXXLAASA-N,
ACT04747,
Tox21_112221,
2694AH,
FC1264,
MFCD02102164,
s4058,
AKOS015900322,
AKOS015994752,
Tox21_112221_1,
AN-9624,
API0007295,
CCG-101108,
KS-5134,
NC00358,
NCGC00164597-02,
CPD000469137,
H838,
N-(2,6-dimethylphenyl)-1-propyl-piperidine-2-carboxamide; hydron; chloride,
SAM001246524,
SC-26798,
SMR000469137,
ropivacaine monohydrochloride, (S)-isomer,
LS-113954,
CS-0013146,
FT-0674459,
ST24049128,
SW197738-2,
717R158,
I14-176,
Q-201678,
2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-propyl-,monohydrochloride, (2S)-,
Ropivacaine,
C17-H26-N2-O.Cl-H,
UNII-V910P86109,
CID175804,
ACN-034401,
CS-O-31018,
ROPIVACAINE HYDROCHLORIDE MONOHYDRATE,
B2023,
2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-propyl-, hydrochloride, hydrate (1:1:1), (2S)-,
4826-71-5,
84057-95-4,